The University of Pennsylvania Prevention Research Center (UPenn PRC), led by Drs. Karen Glanz, Oluwadamilola “Lola” Fayanju, and Meghan Lane-Fall, has been awarded a core grant and supplement totaling $6.5 million from the Centers for Disease Control and Prevention (CDC) for the next five years.

Dr. Karen Glanz, a George A. Weiss University Professor at the University of Pennsylvania, has been recognized as one of the Top Female Scientists in the world for the third consecutive year.

The Center for Health Behavior Research at the University of Pennsylvania is seeking a talented and highly motivated postdoctoral fellow to join the Center. The Center, directed by Dr. Karen Glanz, focuses on advancing the development, application, and testing of health behavior measurement and theories.

The fundamentals of theory and conceptual frameworks for explaining and changing health-related behavior enable students and professionals to make important impacts on the health of populations.  The authors wrote this new edition to communicate these ideas, applied to new and emerging public health issues and concerns.

The goal of PC3 is to empower Philadelphians to reduce cancer disparities through community engagement, resource alignment, information sharing, research, and prevention. A training session was held on May 4 with community members recruited by the cancer research collaboration.

Karen Glanz spoke to The Daily Pennsylvanian about the pricing differences in local grocery stores.

HUGE congrats to Dr. Glanz, a top 10 most-cited researcher at Penn! Your work in health behavior research is inspiring!

Highlights from the 2024 Community-Driven Research Day! This event encourages collaboration between community organizations & researchers from local academic institutions to answer questions with community benefit.

The latest cancer statistics report from the American Cancer Society (ACS) paints a complex picture of our struggle against the disease. While cancer mortality rates are declining, a worrying trend emerges: younger people are being diagnosed at an increasing rate. This bittersweet news highlights both the progress we've made and the challenges that lie ahead.

Karen Glanz, PhD, MPH, received two distinguished honors in the month of November. Glanz became a Fellow of the College of Physicians of Philadelphia and was named one of the Best Female Scientists for the 2nd year in a row.